50V Stock Chart & Stats
€0.01
€0.00(0.00%)
At close: 4:00 PM EST
€0.01
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.05
Previous CloseN/A
Volume0.00
Average Volume (3M)96.68K
Market Cap
€3.65M
Enterprise Value€45.75
Total Cash (Recent Filing)€1.92M
Total Debt (Recent Filing)€7.98M
Price to Earnings (P/E)―
Beta-104.72
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding204,569,100
10 Day Avg. Volume16,562
30 Day Avg. Volume96,679
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)-5.45
Price to Sales (P/S)1.34
P/FCF Ratio-14.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Employer-focused Digital Health PlatformThe company addresses an ongoing employer need by combining health, absence and work-ability processes in a data-driven platform, supporting a business model that can generate software access, implementation and service revenue.
Losses Have Narrowed From Prior YearsAlthough profitability remains deeply negative, the improvement from earlier loss levels indicates some progress in cost structure or operating efficiency. Sustaining that trend could improve the company’s path toward eventual operating breakeven.
Cash Burn Improved Versus 2022Lower cash consumption than in 2022 suggests the business has made some progress in controlling operating cash losses. Further improvement would reduce dependence on external funding, although current cash generation remains negative and volatile.
Bears Say
Negative Equity And Highly Constrained Balance SheetThe equity deficit and debt exceeding total assets indicate a very thin capital base. This limits financial flexibility, increases refinancing and funding risk, and leaves the company vulnerable if operating losses continue.
Persistent Negative Cash GenerationOngoing operating and free cash outflows mean the business is not currently self-funding. Continued cash burn can require financing or capital support, potentially diluting shareholders or restricting investment in product and customer growth.
Structural Unprofitability And Declining RevenueRevenue contraction combined with deeply negative operating and net margins shows that the current scale and cost base do not support sustainable profitability. Without stronger growth or substantial margin improvement, losses may remain persistent.
50V FAQ
What was Aino Health AB’s price range in the past 12 months?
Aino Health AB lowest stock price was <€0.01 and its highest was €0.05 in the past 12 months.
What is Aino Health AB’s market cap?
Aino Health AB’s market cap is €3.65M.
When is Aino Health AB’s upcoming earnings report date?
Aino Health AB’s upcoming earnings report date is Nov 12, 2026 which is in 76 days.
How were Aino Health AB’s earnings last quarter?
Aino Health AB released its earnings results on Aug 17, 2026. The company reported -€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Aino Health AB overvalued?
According to Wall Street analysts Aino Health AB’s price is currently Overvalued.
Does Aino Health AB pay dividends?
Aino Health AB does not currently pay dividends.
What is Aino Health AB’s EPS estimate?
Aino Health AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aino Health AB have?
Aino Health AB has 204,569,100 shares outstanding.
What happened to Aino Health AB’s price movement after its last earnings report?
Aino Health AB reported an EPS of -€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of Aino Health AB?
Currently, no hedge funds are holding shares in DE:50V
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aino Health AB
Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Software-as-a-Service (SaaS) platform equipped with tools for health surveys, analytical insights, exposure checks, and compliance with security and GDPR regulations, along with an integrated e-learning module. Beyond the software, Aino Health provides a range of additional services, including telemedicine, professional support (such as analytics, management/employee guidance, and well-being programs), and onboarding assistance covering project management, implementation, and training. The company also extends its services to a diverse network of partners, including occupational health providers, insurance companies, IT firms, HR/payroll service centers, and various healthcare practitioners.
Technical Analysis
Humana AB
―
Q-linea AB
―
Kontigo Care AB
―
Surgical Science Sweden AB
―
Physitrack Limited
―